Release Date: November 23rd, 2016
Expiration date: May 23rd, 2017
Estimated Time to Complete Activity: 25 minutes
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
OVERVIEW
In this webcast experts in the field of cardiology discuss the future of low risk TAVR procedures and new criteria for TAVR use in patients, including STS scores, frailty, and disability for enrollment in a low risk trial.
During this webcast, participants will learn how patients will benefit from TAVR and the implications for surgeons and interventionalists, how the new data available for devices will improve patient outcomes, and gain insight into the importance of creating a comprehensive team approach that includes surgeons and interventionalists.
LEARNING OBJECTIVES
After participating in this event, learners will be able to:
- Discuss the changes to TAVR and what it means to patients
- Explore the options available to interventionalists and surgeons
- Describe the patient population that will benefit from the future of low risk TAVR
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other health care professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Faculty
Michael Reardon (C/H/S) Medtronic
Jeffrey Popma (G/R) Abiomed, Abbott, Biotronik, Boston Scientific Corporation, Medtronic, Direct Flow (C/H/S) Boston Scientific Corporation, Direct Flow (E) Direct Flow
Vinod Thourani (G/R) Medtronic, Boston Scientific Corporation, St. Jude Medical, Abiomed, Abbott, Edwards Lifesciences
Steven Yakubov (C/H/S) Abbott, Boston Scientific Corporation, Medtronic, St. Jude Medical
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Edwards Lifesciences and Medtronic Inc. and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Gelardi at agelardi@crf.org